Skip to main content
Clinical Trials/NCT03453827
NCT03453827
Completed
Not Applicable

Assessment of Long-term Intraocular Lens (IOL) Decentration and Tilt in Eyes With Pseudoexfoliation Syndrome (PES) Following Cataract Surgery

Hospital Hietzing0 sites37 target enrollmentApril 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataract
Sponsor
Hospital Hietzing
Enrollment
37
Primary Endpoint
IOL tilt
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

To evaluate long-term intraocular lens (IOL) decentration and tilt in eyes with pseudoexfoliation syndrome (PES) following cataract surgery using Visante anterior segment OCT and iTrace Visual Function Analyzer.

Detailed Description

64 eyes following cataract surgery from 2009 to 2012 were included, 34 eyes had PES, 30 eyes did not show PES. A standard phacoemulsification procedure followed by IOL implantation was performed and patients were followed 4-6 years after surgery (mean=69 months). Best corrected visual acuity (BCVA), intraocular pressure (IOP) and capsulorhexis size were measured. IOL tilt and IOL decentration were evaluated using Visante Omni anterior segment OCT (Carl Zeiss Jena GmBH, Germany). The iTrace VFA (Visual Function Analyzer, Topcon Medical Systems, Inc.) was used to measure internal, corneal and total optical aberrations.

Registry
clinicaltrials.gov
Start Date
April 1, 2016
End Date
April 28, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hospital Hietzing
Responsible Party
Principal Investigator
Principal Investigator

Kata Mihaltz

Oberarzt M.D. PhD FEBO

Hospital Hietzing

Eligibility Criteria

Inclusion Criteria

  • patients 4-6 years after standard cataract surgery
  • pseudoexfoliation Syndrome (PES)

Exclusion Criteria

  • Diabetic retinopathy
  • Age related macula Degeneration
  • retinal bloodvessel disease

Outcomes

Primary Outcomes

IOL tilt

Time Frame: 4-6 years after cataract surgery

tilt of implanted IOL is measured using Zeiss OCT

IOL decentration

Time Frame: 4-6 years after cataract surgery

decentration of IOL is measured using Zeiss OCT

Similar Trials